These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 13678297)

  • 1. Modeling and docking of the three-dimensional structure of the human melanocortin 4 receptor.
    Yang X; Wang Z; Dong W; Ling L; Yang H; Chen R
    J Protein Chem; 2003 May; 22(4):335-44. PubMed ID: 13678297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.
    Pogozheva ID; Chai BX; Lomize AL; Fong TM; Weinberg DH; Nargund RP; Mulholland MW; Gantz I; Mosberg HI
    Biochemistry; 2005 Aug; 44(34):11329-41. PubMed ID: 16114870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.
    Chai BX; Pogozheva ID; Lai YM; Li JY; Neubig RR; Mosberg HI; Gantz I
    Biochemistry; 2005 Mar; 44(9):3418-31. PubMed ID: 15736952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling and docking the endothelin G-protein-coupled receptor.
    Orry AJ; Wallace BA
    Biophys J; 2000 Dec; 79(6):3083-94. PubMed ID: 11106614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4,D-Phe7]-alpha-melanocyte-stimulating [corrected] hormone binding and signaling.
    Chen M; Cai M; Aprahamian CJ; Georgeson KE; Hruby V; Harmon CM; Yang Y
    J Biol Chem; 2007 Jul; 282(30):21712-9. PubMed ID: 17545153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling.
    Yang Y; Cai M; Chen M; Qu H; McPherson D; Hruby V; Harmon CM
    Regul Pept; 2009 Jun; 155(1-3):46-54. PubMed ID: 19303903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of ligand binding to the human melanocortin-4 receptor.
    Yang YK; Fong TM; Dickinson CJ; Mao C; Li JY; Tota MR; Mosley R; Van Der Ploeg LH; Gantz I
    Biochemistry; 2000 Dec; 39(48):14900-11. PubMed ID: 11101306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the transmembrane domain 6 of melanocortin-4 receptor to peptide [Pro5, DNal (2')8]-gamma-MSH selectivity.
    Chen M; Cai M; McPherson D; Hruby V; Harmon CM; Yang Y
    Biochem Pharmacol; 2009 Jan; 77(1):114-24. PubMed ID: 18930713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin.
    Trabanino RJ; Hall SE; Vaidehi N; Floriano WB; Kam VW; Goddard WA
    Biophys J; 2004 Apr; 86(4):1904-21. PubMed ID: 15041637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
    Fleck BA; Ling N; Chen C
    Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide.
    Prusis P; Schiöth HB; Muceniece R; Herzyk P; Afshar M; Hubbard RE; Wikberg JE
    J Mol Graph Model; 1997 Oct; 15(5):307-17, 334. PubMed ID: 9640562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cannabinoid receptor: computer-aided molecular modeling and docking of ligand.
    Mahmoudian M
    J Mol Graph Model; 1997 Jun; 15(3):149-53, 179. PubMed ID: 9457616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel binding motif of ACTH analogues at the melanocortin receptors.
    Yang Y; Hruby VJ; Chen M; Crasto C; Cai M; Harmon CM
    Biochemistry; 2009 Oct; 48(41):9775-84. PubMed ID: 19743876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.
    Chapman KL; Kinsella GK; Cox A; Donnelly D; Findlay JB
    J Mol Biol; 2010 Aug; 401(3):433-50. PubMed ID: 20600126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
    Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
    Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational study of the heterodimerization between mu and delta receptors.
    Liu X; Kai M; Jin L; Wang R
    J Comput Aided Mol Des; 2009 Jun; 23(6):321-32. PubMed ID: 19214754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the structure of opioid receptors with homology modeling based on single and multiple templates and subsequent docking: a comparative study.
    Bera I; Laskar A; Ghoshal N
    J Mol Model; 2011 May; 17(5):1207-21. PubMed ID: 20661609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.